EFM
FOLD

E Fund Management’s Amicus Therapeutics FOLD Stock Holding History

E Fund Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$585K Buy
+40,461
New +$580K 0.02% 256
2025
Q2 		$265K Buy
46,326
+22,610
+95% +$146K 0.01% 326
2025
Q1 		$194K Buy
23,716
+21
+0.1% +$194 0.01% 365
2024
Q4 		$223K Sell
23,695
-2,472
-9% -$25.7K 0.01% 349
2024
Q3 		$279K Sell
26,167
-1,567
-6% -$17.1K 0.01% 271
2024
Q2 		$275K Sell
27,734
-7,498
-21% -$77K 0.02% 244
2024
Q1 		$415K Sell
35,232
-7,316
-17% -$93.6K 0.03% 206
2023
Q4 		$604K Buy
42,548
+6,171
+17% +$70.1K 0.04% 124
2023
Q3 		$442K Buy
36,377
+1,510
+4% +$19.5K 0.03% 146
2023
Q2 		$438K Buy
34,867
+1,109
+3% +$13.2K 0.03% 141
2023
Q1 		$374K Sell
33,758
-2,403
-7% -$29.6K 0.03% 189
2022
Q4 		$442K Sell
36,161
-5,551
-13% -$62.5K 0.04% 158
2022
Q3 		$435K Sell
41,712
-10,727
-20% -$120K 0.04% 162
2022
Q2 		$563K Buy
52,439
+23,564
+82% +$194K 0.05% 125
2022
Q1 		$273K Buy
28,875
+12,006
+71% +$113K 0.01% 228
2021
Q4 		$195K Buy
16,869
+1,098
+7% +$12.2K 0.01% 267
2021
Q3 		$151K Buy
+15,771
New +$161K 0.01% 250
2021
Q1 		$127K Buy
+12,862
New +$199K 0.01% 230

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

E Fund Management's FOLD Position: Q1 2026 in Review

E Fund Management opened a new position in Amicus Therapeutics (FOLD) in Q1 2026: 40,461 shares worth $585K. The stake represents 0.02% of the portfolio and ranks #256 among its holdings. This is a return to the name: E Fund Management previously reported a position in FOLD as recently as Q2 2025.

E Fund Management first reported a position in FOLD in Q1 2021 and has held it in 18 quarters since. The position peaked at $604K in Q4 2023. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • E Fund Management held 40,461 shares of Amicus Therapeutics worth $585K as of Q1 2026.
  • Amicus Therapeutics was a new E Fund Management position in Q1 2026.
  • Amicus Therapeutics made up 0.02% of E Fund Management's portfolio in Q1 2026, its #256 holding.
  • E Fund Management first reported a position in Amicus Therapeutics in Q1 2021 and has held it in 18 quarters since.
  • E Fund Management's Amicus Therapeutics position peaked at $604K in Q4 2023.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on E Fund Management's 13F filing for Q1 2026, filed 13 Apr 2026.